Project Grant HT94252510017
Award Date
9/1/25
Completion Date
8/31/27
Dollars Obligated
$434K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19122, USA
Similar Awards
Temple University-Of The Commonwealth System Of Higher Education received a $315,618 project grant award from the Defense Health Agency through the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from June 1, 2023 through May 31, 2025 examining the role of exosomes on the alveolar epithelium in idiopathic pulmonary fibrosis. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research...
The federal Project Grant award of $1,585,000.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award, effective March 1, 2025 through February 28, 2029, supports advanced biomedical research at Temple University-Of The Commonwealth System Of Higher Education aimed at "TARGETING LYMPHATIC CHEMOKINE SIGNALING TO PROMOTE LYMPHANGIOGENESIS FOR THE TREATMENT OF LYMPHEDEMA". The grant funding will enable Temple...
Temple University was awarded a $2.53 million Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research into the role of TRAF6 in primary alveolar epithelial cell injury from September 2021 through September 2025. As part of the Military Medical Research and Development program's goals to transform military and public health through innovative medical research, this project will...
This federal Project Grant award of $435,876.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award, effective March 1, 2025 through February 28, 2027, supports advanced biomedical research by Temple University to investigate KIF11, a novel therapeutic target for lymphedema. The research aims to transform healthcare for military service members, veterans, and the broader public by developing innovative solutions to...
This Project Grant award in the amount of $679,085.00 was issued by the Defense Health Agency, a component of the Department of Defense, under the Military Medical Research and Development program (CFDA 12.420). The funding supports research by Temple University-Of The Commonwealth System Of Higher Education, through its division Temple University, to investigate the role of tumor-associated sensory neurons in breast cancer invasion and metastasis. The award period runs from January 15, 2024...
This Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) provides $434,492 to Temple University to conduct research on "Mitochondrial Transplantation as a Novel Therapy for Lung Fibrosis". The award period runs from June 1, 2025 to May 31, 2027. The Military Medical Research and Development program supports advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. This...
The federal Project Grant award of $3,300,817.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research at the Icahn School of Medicine at Mount Sinai (ISMMS) to leverage personalized stem cell therapy and overcome airway reconstruction challenges. This research aims to transform healthcare for military service members, veterans, and the broader public by addressing critical health...
The U.S. Defense Health Agency awarded a $1,999,996 Project Grant to Temple University under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research to identify diagnostic biomarkers of cerebrovascular contributions to cognitive impairment in repeated blast concussion. This 4-year research project, running from June 2025 to May 2029, aims to transform healthcare for military service members, veterans, and the broader public by...
This federal Project Grant award for $1,178,136.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research by the University of Pennsylvania to exploit the absence of TP53 mutations in epithelial ovarian cancer using next-generation p53-stabilizing agents. The award has a performance period from April 15, 2025 to April 19, 2029 and aims to transform healthcare for military service members, veterans, and the broader...
The Department of the Army Medical Command awarded a $1,188,750.00 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to Temple University to support research aimed at identifying therapeutic peptide drugs for regenerating visual pathways. The award, effective September 15, 2024, will fund this initiative over a 3-year period through September 14, 2027. As a prominent public research university, Temple University has extensive experience conducting advanced...